Candidiasis Market to Witness Steady Growth Rate During 2018 to 2026

Candidiasis Market Size,
Outlook, Future Growth
Synthesis By 2026
Share, Trend,
Analysis And
Candidiasis is a type of infection caused due to candida—an yeast and also classified as fungus, which is
present in the human body. It is usually present in places like mouth, belly, and on the skin. The
overgrowth of these leads to an infection. This dormant yeast can lead to candida infection at any stage
in a person’s life and is closely linked to the immunity level of the person. There are various types of
infections caused due to candidiasis, such as thrush/ oropharyngeal candidiasis, genital yeast infection/
invasive infection, and cutaneous candidiasis. Thrush/ oropharyngeal candidiasis affects the mouth or
throat; genital yeast infection affects the vagina; and cutaneous candidiasis is the infection of the skin.
When the infection enters into the blood stream, the condition is called Candidemia. Candidiasis can be
diagnosed by physical observation. These conditions are usually treated using over-the-counter antifungal
medicines and also specific prescription-based antifungal medicines.
Download PDF Brochure of This Business Report @
https://www.coherentmarketinsights.com/insight/request-pdf/229
Increasing consumer awareness about candidiasis and growing number of treatment options are major
factors fueling growth of the candidiasis market. Conversely, dearth of R&D activities, low product
availability, and easy access to alternative treatment methods such as use of herbal medicines inhibits
growth of the candidiasis market.
Rising awareness regarding the infection and increasing patient pool to favor the growth of Candidiasis
market
Rising awareness about the infections is expected to cause the growth of candidiasis market. Increasing
focus of various governments in the APAC region, such as in highly populous China and India, on
improving the healthcare infrastructure, along with increasing consumer awareness about the condition is
expected to position the region on a high growth trajectory in the global candidiasis industry over the
forecast period (2016–2024). Candidiasis are treated using various treatment option such as oral
medication, injection, and ointments. Candidiasis can infect males, females and also newborn babies.
The condition is notoriously hard to treat in people suffering from diabetes, cancer, AIDS, and also
pregnant women. As per stats released by Centers for Disease Control and Prevention (CDC), around 75%
of would suffer from at least one vaginal candida infection in their whole life, while 40-45% would
suffer twice or more.
Report includes chapters which deeply display the following deliverable about industry :
• Candidiasis Market Research Objective and Assumption
• Candidiasis Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Candidiasis Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Candidiasis Market, By Regions
• Candidiasis Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Candidiasis Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Candidiasis Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Candidiasis Market Forecast including Production, Consumption, Import and Export Forecast
by Type, Applications and Region.
• Research Findings and Conclusion
Major Key Players
The major market players in Candidiasis market are Bayer, Teva Pharmaceuticals, Stellar Pharma, Pfizer,
Wockhardt, Glenmark Pharmaceuticals, Ranbaxy, Taro Pharmaceuticals, and Bristol Laboratories, among
others.
Candidiasis Market Taxonomy:
This market is segmented by as followsBy Route of Administration:
•
Oral
•
Parenteral
•
Topical
By Type of Infection:
•
Thrush/ oropharyngeal candidiasis
•
Genital Yeast Infection/ Invasive infection
•
Cutaneous Candidiasis
Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoinginsight/candidiasis-market-229
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Increasing consumer awareness about candidiasis and growing number of treatment options are major factors fueling growth of the candidiasis market.